Show
Sort by
-
- Journal Article
- A2
- open access
Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants : real-world evidence from MSBase
-
- Journal Article
- A1
- open access
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic
-
- Journal Article
- A1
- open access
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis : recruitment challenges, potential bias, and statistical strategies
-
- Journal Article
- A2
- open access
Machine-learning-based prediction of disability progression in multiple sclerosis : an observational, international, multi-center study
-
- Journal Article
- A1
- open access
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis : a longitudinal analysis of global and national registries
-
- Journal Article
- A1
- open access
Comparison between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation
-
Comparative effectiveness in multiple sclerosis : a methodological comparison
-
- Journal Article
- A1
- open access
Disability accrual in primary and secondary progressive multiple sclerosis
-
- Journal Article
- A1
- open access
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis
-
- Journal Article
- A1
- open access
Rituximab vs ocrelizumab in relapsing-remitting multiple sclerosis